Application of kinsenoside in preparation of drug for treating insulin resistance
A technology for insulin resistance and clematis glycosides is applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, which can solve problems such as unclear molecular mechanisms, improve insulin resistance and type 2 diabetes, and increase intake. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0018] The present invention provides the application of aureoside in the preparation of medicines for treating insulin resistance or type 2 diabetes. In order to make the purpose, technical scheme and effect of the present invention clearer and clearer, the present invention will be further described in detail below. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
[0019] In the present invention, using rat skeletal muscle cells as a model, in the case of insulin sensitivity and insulin resistance, the activation of protein kinases Akt and AMPK by auroside was detected by Western blot method, and fluorescently labeled 2-deoxy Glucose is an energy substrate to detect the uptake of glucose by cells before and after treatment with auroglucoside. The results showed that in normal cells, auroside can significantly increase the activity of Akt and AMPK and promote the uptake of...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


